CN106334176B - 一种可以消肿止痛止痒的冻疮膏及其制备方法 - Google Patents
一种可以消肿止痛止痒的冻疮膏及其制备方法 Download PDFInfo
- Publication number
- CN106334176B CN106334176B CN201610917697.8A CN201610917697A CN106334176B CN 106334176 B CN106334176 B CN 106334176B CN 201610917697 A CN201610917697 A CN 201610917697A CN 106334176 B CN106334176 B CN 106334176B
- Authority
- CN
- China
- Prior art keywords
- extracting
- water
- time
- weight
- weighing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000010445 Chilblains Diseases 0.000 title claims abstract description 58
- 208000002193 Pain Diseases 0.000 title claims abstract description 43
- 230000036407 pain Effects 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- 206010042674 Swelling Diseases 0.000 title claims abstract description 35
- 230000008961 swelling Effects 0.000 title claims abstract description 35
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 25
- 230000007803 itching Effects 0.000 title claims abstract description 25
- 239000002674 ointment Substances 0.000 title claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 191
- 239000000284 extract Substances 0.000 claims abstract description 42
- 244000276331 Citrus maxima Species 0.000 claims abstract description 28
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 27
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 27
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 27
- 244000291564 Allium cepa Species 0.000 claims abstract description 26
- 235000001759 Citrus maxima Nutrition 0.000 claims abstract description 26
- 239000012153 distilled water Substances 0.000 claims abstract description 26
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 25
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 25
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 25
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229920000609 methyl cellulose Polymers 0.000 claims abstract description 22
- 239000001923 methylcellulose Substances 0.000 claims abstract description 22
- 241000758794 Asarum Species 0.000 claims abstract description 21
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 21
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 21
- 235000008397 ginger Nutrition 0.000 claims abstract description 21
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 18
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 18
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 18
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000013078 crystal Substances 0.000 claims abstract description 12
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims abstract description 12
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims abstract description 12
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 12
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 12
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 12
- 229960002216 methylparaben Drugs 0.000 claims abstract description 12
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 claims abstract description 7
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims abstract description 6
- 229960004063 propylene glycol Drugs 0.000 claims abstract description 6
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 5
- 244000273928 Zingiber officinale Species 0.000 claims abstract 5
- 239000000706 filtrate Substances 0.000 claims description 90
- 238000010438 heat treatment Methods 0.000 claims description 80
- 238000005303 weighing Methods 0.000 claims description 80
- 238000001914 filtration Methods 0.000 claims description 63
- 238000002791 soaking Methods 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 37
- 238000003756 stirring Methods 0.000 claims description 30
- 235000010981 methylcellulose Nutrition 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 18
- 238000005520 cutting process Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 10
- 229940119485 safflower extract Drugs 0.000 claims description 8
- 229940002508 ginger extract Drugs 0.000 claims description 7
- 235000020708 ginger extract Nutrition 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229940064064 purslane extract Drugs 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- 240000008067 Cucumis sativus Species 0.000 claims description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 2
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 2
- 240000005385 Jasminum sambac Species 0.000 claims description 2
- 244000242564 Osmanthus fragrans Species 0.000 claims description 2
- 235000019083 Osmanthus fragrans Nutrition 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 241000220317 Rosa Species 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 235000013616 tea Nutrition 0.000 claims 2
- 230000017531 blood circulation Effects 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 208000001034 Frostbite Diseases 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 206010013786 Dry skin Diseases 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 230000037336 dry skin Effects 0.000 abstract description 3
- 210000003205 muscle Anatomy 0.000 abstract description 3
- 239000000686 essence Substances 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 241000219304 Portulacaceae Species 0.000 description 16
- 241000234314 Zingiber Species 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 239000000499 gel Substances 0.000 description 15
- 239000006071 cream Substances 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MLFIYYDKLNZLAO-UHFFFAOYSA-N 2-aminoethane-1,1-diol Chemical compound NCC(O)O MLFIYYDKLNZLAO-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 206010002512 anhidrosis Diseases 0.000 description 1
- 230000037001 anhydrosis Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000005536 corrosion prevention Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 230000002884 effect on inflammation Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- JAOZKJMVYIWLKU-UHFFFAOYSA-N sodium 7-hydroxy-8-[(4-sulfonaphthalen-1-yl)diazenyl]naphthalene-1,3-disulfonic acid Chemical compound C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)O)N=NC3=C(C=CC4=CC(=CC(=C43)S(=O)(=O)O)S(=O)(=O)O)O.[Na+] JAOZKJMVYIWLKU-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000013460 sweaty Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000004520 water soluble gel Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明提供了一种可以消肿止痛止痒的冻疮膏及其制备方法,配方包括:卡波姆941,甲基纤维素,羧甲基纤维素钠,冰晶形成剂AVC,QM凝胶形成剂,柚子皮提取液,葱白提取液,细辛提取液,桂枝提取液,红花提取液,生姜提取液,桂圆提取液,羌活提取液,马齿苋提取液,1,2‑丙二醇、尼泊金甲酯,尼泊金乙酯,蒸馏水和香精。与现有技术相比,本发明从九种药物中提取天然成分,可以止痒生肌,活血化瘀,消肿散寒,能预防和治疗冻伤,养肌护肤,同时还可以解决皮肤干燥,手足皴裂等问题。
Description
技术领域
本发明属于医药领域,具体涉及一种可以消肿止痛止痒的冻疮膏及其制备方法。
背景技术
严寒是导致冻疮形成的主要原因,其发病原因是冻疮患者的皮肤在遇到寒冷(0~10℃)、潮湿或冷暖急变时,局部小动脉发生收缩,久而久之动脉血管就会因麻痹而发生扩张,导致静脉淤血,局部血液循环不畅而最终长出冻疮。此外,患者自身的皮肤湿度、末梢微血管畸形、自主性神经功能紊乱、营养不良、内分泌障碍等因素也可能参与发病。缺乏运动、手足多汗潮湿、鞋袜过紧及长期户外低温下工作等因素均可致使冻疮的发生。
冻疮一般都多生长在手脚的末端和耳朵部位,也会有人生长在脸上,主要因为这些地方都离心脏比较远,所以血液循环比较弱,再加上长时间的寒冷刺激导致损伤,就形成了冻疮。冻疮好发于初冬、早春季节,以儿童、妇女和末梢血液循环不良者多见,这些患者常伴有肢体末端皮肤发凉、肢端发绀、多汗等表现。常见损害为局限性淤血性暗紫红色隆起的水肿性红斑。严重者可发生水疱,破裂形成糜烂或溃疡,愈后存留色素沉着或萎缩性瘢痕。痒感明显,遇热后加剧,溃烂后疼痛。
产生冻疮的直接原因是受冻,然而其根本原因是自身免疫力低下,御寒能力不足,因此要提高肌肤的免疫能力才是解决冻疮的根本问题。
目前医药市场治疗冻疮、冻伤皆是传统的化学产品,从作用原理上论述,化学产品难以迅速治愈冻伤、冻疮。
发明内容
本发明的目的在于提供一种可以消肿止痛止痒的冻疮膏及其制备方法,含有中药的有效成分,可以有效的预防、治疗冻疮。
本发明提供的一种可以消肿止痛止痒的冻疮膏,含有以下重量份的原料:
所述的柚子皮提取液通过以下方法制备:
称取柚子皮适量,剪碎后浸泡0.15-0.8h,加热煎煮提取3次,第1次加15-20倍重量的水,提取1-2.5h,第2次加12-18倍重量的水,提取1-2h,第3次加8-12倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至柚子皮重量的3-5倍g/ml,过滤即得。
所述的葱白提取液通过以下方法制备:
称取葱白适量,切碎,浸泡0.15-0.8h,加热煎煮提取3次,第1次加12-16倍重量的水,提取1-2.5h,第2次加10-15倍重量的水,提取0.5-1.5h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至葱白重量的2-7倍g/ml,过滤即得。
所述的细辛提取液通过以下方法制备:
称取细辛粗粉适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加12-20倍重量的水,提取1-2.5h,第2次加10-16倍重量的水,提取1-2.5h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至细辛重量的3-6倍g/ml,过滤即得。
所述的桂枝提取液通过以下方法制备:
称取桂枝粗粉适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加15-20倍重量的水,提取1-2.5h,第2次加10-15倍重量的水,提取0.5-1.5h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至桂枝重量的1-4倍g/ml,过滤即得。
所述的生姜提取液通过以下方法制备:
称取生姜适量,切碎,浸泡0.15-0.8h,加热煎煮提取3次,第1次加13-20倍重量的水,提取1-2.5h,第2次加10-15倍重量的水,提取1-2h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至生姜重量的3-7倍g/ml,过滤即得。
所述的红花提取液通过以下方法制备:
称取红花适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加18-25倍重量的水,提取1-3h,第2次加15-18倍重量的水,提取1-1.5h,第3次加8-12倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至红花重量的5-8倍g/ml,过滤即得。
所述的桂圆提取液通过以下方法制备:
称取桂圆适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加18-25倍重量的水,提取1-3h,第2次加15-20倍重量的水,提取1-2h,第3次加10-15倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至桂圆重量的3-6倍g/ml,过滤即得。
所述的羌活提取液通过以下方法制备:
称取羌活粗粉适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加15-20倍重量的水,提取1-2.5h,第2次加12-15倍重量的水,提取1-2h,第3次加8-12倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至羌活重量的4-7倍g/ml,过滤即得。
所述的马齿苋提取液通过以下方法制备:
称取马齿苋适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加12-15倍重量的水,提取0.5-2h,第2次加10-12倍重量的水,提取0.5-1.5h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至马齿苋重量的3-6倍g/ml,过滤即得。
所述的香精为青瓜香精、茉莉香精、桂花香精、玫瑰香精、水蜜桃香精、菠萝香精或柠檬香精中任一种。
本发明提供的一种可以消肿止痛止痒的冻疮膏的制备方法,包括以下步骤:
a)称取卡波姆941 0.1-1份,加入到40-80份的蒸馏水中,40-70℃水浴加热,边加热边搅拌,待混合均匀后,静置让其充分溶胀,待用;
b)称取甲基纤维素0.1-1份,加入到装有40-80份蒸馏水的烧杯中,静置让其充分溶胀,待用;
c)称取羧甲基纤维素钠0.05-0.5份,加入到装有30-60份蒸馏水的烧杯中,静置让其充分溶胀,待用;
d)称取冰晶形成剂AVC0.1-1份,加入到装有40-80份蒸馏水的烧杯中,40-70℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
e)称取QM凝胶形成剂0.3-1份,加入到装有50-80份蒸馏水的烧杯中,40-70℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
f)分别称取柚子皮提取液0.5-5份,葱白提取液1-6份,细辛提取液1-6份,桂枝提取液0.5-5份,生姜提取液1-6份,红花提取液1-5份,桂圆提取液0.5-4份,羌活提取液1-6份和马齿苋提取液0.5-6份搅拌均匀,得混合溶液;
g)取先前溶胀好的卡波姆941,甲基纤维素,羧甲基纤维素钠,冰晶形成剂AVC和QM凝胶形成剂搅拌均匀,得混合凝胶;
h)称取尼泊金甲酯0.01-0.08份、尼泊金乙酯0.01-0.08份,加入1,2-丙二醇2-6份加热使其溶解,然后加入到混合凝胶中,再将得到的混合物与步骤f)得到的混合溶液混匀,加入香精0.05-0.2份,搅拌均匀,即得可以消肿止痛止痒的冻疮膏。
本发明中的各种成分如下:
柚子皮含有非常丰富的蛋白质,有机酸,维生素以及钙,磷,镁,钠等人体必需的元素。现代中医认为,柚子皮中含有一种生理活性物质,叫做柚皮苷,可以降低血液的粘稠度,减少血栓形成,加快血液循环,活血化瘀,有利于冻疮肌肤的修复。柚子皮煮水治冻疮效果较好,还有止痛效果。
葱白有发汗解表,散寒通阳的功效,外敷治疗疮痈疔毒。《本草纲目》:葱,所治之症,多属太阴、阳明,皆取其发散通气之功。通气故能解毒及理血病。气者,血之帅也,气通则血活矣。金疮磕损,折伤血出,疼痛不止者。王嵺《百一方》用葱白、砂糖等分研封之,云痛立止,更无痕瘢也。
桂圆富含维生素和磷质,有滋补强体,补心安神、养血壮阳,益脾开胃,润肤美容,提高肌体免疫力的功效。桂圆核有理气、化湿、止血、定痛等功效,适用于创伤出血、癣疥、湿疮等症。
生姜性热,能够快速驱寒,消肿止痛,杀菌解毒,可治疗各种痈肿疮毒。对于由于受风寒引起的冻疮来说是再好不过的了,同时具有活血,抑菌的作用,可以对冻疮处有保护作用,防治细菌感染的作用。生姜泥和生姜浸出液对创伤愈合有明显的促进作用。
细辛有祛风散寒、止痛通窍、止咳平喘和通利血脉等功效。其挥发油对家兔有镇痛作用,其镇痛强度与安替匹林0.5mg/kg相当。细辛有抗炎效果,可以抑制炎症介质的释放,同时抑制结缔组织的增生,对于冻疮患者来说可以消炎,止痛。
红花具有活血调经,祛瘀止痛,散湿去肿,促进血液循环,通络等功效,可用于跌打损伤、疮疡肿痛。《本草纲目》记载:活血,润燥,止痛,散肿,通经。《本草正》记载:达痘疮血热难出,散斑疹血滞不消。《本草再新》记载:利水消肿。
桂枝味辛,甘,性温,可以温通经脉,散寒止痛,消肿,可用于肩背肢节酸疼,水肿,而且对金黄色葡萄球菌等多种细菌有抑制作用,对炎症也有很好效果。《本草再新》记载:温中行血,健脾燥胃,消肿利湿。治手足发冷作麻、筋抽疼痛,并外感寒凉等症。《本草汇言》记载:桂枝,散风寒,逐表邪,发邪汗,止咳嗽,去肢节间风痛之药也。气味虽不离乎辛热,但体属枝条,仅可发散皮毛肌腠之间,游行臂膝肢节之处。
羌活有解表散寒,祛风胜湿利关节,止痛,同时还有消炎解毒等功效。主治感风寒、头痛无汗、寒湿痹、风水浮肿、疮疡肿毒。《品汇精要》记载:主遍身百节疼痛,肌表八风贼邪,除新旧风湿,排腐肉疽疮。
马齿苋含有丰富的二羟乙胺、苹果酸、葡萄糖、钙、磷、铁以及维生素E、胡萝卜素、维生素B、维生素C等营养物质。它能清热解毒,消炎止痛,止血消肿,可用于痈肿恶疮,对伤寒杆菌和大肠杆菌有较强的抑制功能,可用于各种炎症的辅助治疗,素有“天然抗生素”之称。
卡波姆941是优良的凝胶基质,有增稠,悬浮等重要用途,工艺简单,稳定性好,广泛应用乳液,膏霜,凝胶中。羧甲基纤维素钠常用作增稠剂,保水剂,常用于日用化工中。甲基纤维素具有优良的润湿性,分散性,粘接性,增稠性,保水性。
冰晶形成剂AVC可替代卡波姆,无须中和,操作简单,稳定性好,耐酸,且在酸性条件下稳定,轻松DIY凝胶制品必备原料,遇水溶解性强,不用再等待几个小时,直接添加于水相,搅拌均匀即成晶莹剔透的凝胶,同时赋予柔滑的感觉,即使添加比例再大,也不会有起条现象,同时制作过程中不会有扬尘现象。
香精用在产品中对人既有兴奋作用,又有镇静作用,可以清除原产品中的不愉快气味。独特的香精气味更能吸引消费者,有些香精有抑菌、防腐、防霉作用。
本发明中,柚子皮加快血液循环,活血化瘀,有利于冻疮肌肤的修复;葱白散寒通阳,外敷治疗疮痈疔毒;桂圆适用于创伤出血湿疮等症;生姜性热,能够快速驱寒,活血抑菌;细辛可以消炎,止痛;红花具有祛瘀止痛,散湿去肿,促进血液循环,通络等功效;桂枝可以温通经脉,散寒止痛,消肿,可用于肩背肢节酸疼,水肿等;羌活有解表散寒,祛风胜湿利关节,止痛,同时还有消炎解毒等功效;马齿苋清热解毒,消炎止痛,止血消肿。各成分相辅相成,共奏止痒生肌,活血化瘀,消肿消炎,散寒,能预防和治疗冻伤,养肌护肤,同时还可以解决皮肤干燥,手足皴裂等问题。
与现有技术相比,本发明从柚子皮、葱白、细辛、桂枝、生姜、红花、桂圆、羌活、马齿苋九种药物中提取天然成分,可以止痒生肌,活血化瘀,消肿散寒,能预防和治疗冻伤,养肌护肤,同时还可以解决皮肤干燥,手足皴裂等问题。本发明提供的冻疮膏以多功能天然有效成分以及亲肤的水溶性凝胶基质完美结合,有效、快速治愈冻疮,恢复原有肌肤。药用功能及护肤功能两者兼具,在药品行业具有很广阔的市场前景,期望能给更多饱受冻疮困扰的患者带来福音。
具体实施方式
下面结合实施例对本发明做进一步的描述。
实施例1
一种可以消肿止痛止痒的冻疮膏,含有以下重量份的原料:
一种可以消肿止痛止痒的冻疮膏的制备方法,包括以下步骤:
1.1柚子皮提取液的制备
称取柚子皮200g,剪碎后浸泡0.8h,加热煎煮提取3次,第1次加20倍重量的水,提取2h,第2次加18倍重量的水,提取1.5h,第3次加12倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至柚子皮重量的5倍g/ml待用。
1.2葱白提取液的制备
称取葱白200g,切碎后浸泡0.8h,加热煎煮提取3次,第1次加16倍重量的水,提取2h,第2次加15倍重量的水,提取1.5h,第3次加10倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至葱白重量的6倍g/ml待用。
1.3细辛提取液的制备
称取细辛粗粉200g,浸泡0.8h,加热煎煮提取3次,第1次加20倍重量的水,提取2h,第2次加16倍重量的水,提取1.5h,第3次加10倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至葱白重量的5倍g/ml待用。
1.4桂枝提取液的制备
称取桂枝粗粉200g,浸泡0.8h,加热煎煮提取3次,第1次加20倍重量的水,提取2h,第2次加15倍重量的水,提取1.5h,第3次加10倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至桂枝重量的4倍g/ml待用。
1.5生姜提取液的制备
称取生姜200g,切碎后浸泡0.8h,加热煎煮提取3次,第1次加20倍重量的水,提取2h,第2次加15倍重量的水,提取1.5h,第3次加10倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至生姜重量的5倍g/ml待用。
1.6红花提取液的制备
称取红花200g,浸泡0.8h,加热煎煮提取3次,第1次加25倍重量的水,提取2h,第2次加18倍重量的水,提取1.5h,第3次加12倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至红花重量的8倍g/ml待用。
1.7桂圆提取液的制备
称取桂圆200g,浸泡0.8h,加热煎煮提取3次,第1次加25倍重量的水,提取2h,第2次加20倍重量的水,提取1.5h,第3次加15倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至桂圆重量的5倍g/ml待用。
1.8羌活提取液的制备
称取羌活粗粉200g,浸泡0.8h,加热煎煮提取3次,第1次加20倍重量的水,提取2h,第2次加15倍重量的水,提取1.5h,第3次加12倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至羌活重量的6倍g/ml待用。
1.9马齿苋提取液的制备
称取马齿苋200g,浸泡0.8h,加热煎煮提取3次,第1次加15倍重量的水,提取2h,第2次加12倍重量的水,提取1.5h,第3次加10倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至马齿苋重量的6倍g/ml待用。
1.10冻疮膏的制备
a)称取卡波姆941 1g,加入到80g的蒸馏水中,70℃水浴加热,边加热边搅拌,待混合均匀后,静置让其充分溶胀,待用;
b)称取甲基纤维素1g,加入到装有80g蒸馏水的烧杯中,静置让其充分溶胀,待用;
c)称取羧甲基纤维素钠0.5g,加入到装有60g蒸馏水的烧杯中,静置让其充分溶胀,待用;
d)称取冰晶形成剂AVC1g,加入到装有80g蒸馏水的烧杯中,70℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
e)称取QM凝胶形成剂1g,加入到装有80g蒸馏水的烧杯中,70℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
f)分别称取柚子皮提取液5g,葱白提取液6g,细辛提取液6g,桂枝提取液5g,生姜提取液6g,红花提取液5g,桂圆提取液4g,羌活提取液6g,马齿苋提取液6g置于烧杯1中,并搅拌均匀;
g)取先前溶胀好的卡波姆941,甲基纤维素,羧甲基纤维素钠,冰晶形成剂AVC,QM凝胶形成剂加入到烧杯2中,用搅拌机搅拌均匀;
h)称取尼泊金甲酯0.08g、尼泊金乙酯0.08g,加入1,2-丙二醇6g加热使其溶解,待溶解后放入烧杯2中,再将烧杯2的物质放入烧杯1中,往烧杯1中加入香精0.05g,用搅拌机搅拌均匀即得可以消肿止痛止痒的冻疮膏。
实施例2
一种可以消肿止痛止痒的冻疮膏,含有以下重量份的原料:
一种可以消肿止痛止痒的冻疮膏的制备方法,包括以下步骤:
2.1柚子皮提取液的制备
称取柚子皮100g,剪碎后浸泡0.5h,加热煎煮提取3次,第1次加18倍重量的水,提取1.5h,第2次加15倍重量的水,提取1h,第3次加10倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至柚子皮重量的4倍g/ml待用。
2.2葱白提取液的制备
称取葱白100g,切碎后浸泡0.5h,加热煎煮提取3次,第1次加14倍重量的水,提取1.5h,第2次加13倍重量的水,提取1h,第3次加9倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至葱白重量的5倍g/ml待用。
2.3细辛提取液的制备
称取细辛粗粉100g,浸泡0.5h,加热煎煮提取3次,第1次加15倍重量的水,提取1.5h,第2次加13倍重量的水,提取1h,第3次加9倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至细辛重量的4倍g/ml待用。
2.4桂枝提取液的制备
称取桂枝粗粉100g,粉碎后浸泡0.5h,加热煎煮提取3次,第1次加18倍重量的水,提取1.5h,第2次加13倍重量的水,提取1h,第3次加9倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至桂枝重量的3倍g/ml待用。
2.5生姜提取液的制备
称取生姜100g,切碎后浸泡0.5h,加热煎煮提取3次,第1次加15倍重量的水,提取1.5h,第2次加12倍重量的水,提取1h,第3次加9倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至生姜重量的5倍g/ml待用。
2.6红花提取液的制备
称取红花100g,浸泡0.5h,加热煎煮提取3次,第1次加20倍重量的水,提取1.5h,第2次加16倍重量的水,提取1h,第3次加10倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至红花重量的6倍g/ml待用。
2.7桂圆提取液的制备
称取桂圆100g,浸泡0.5h,加热煎煮提取3次,第1次加20倍重量的水,提取1.5h,第2次加18倍重量的水,提取1h,第3次加12倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至桂圆重量的4倍g/ml待用。
2.8羌活提取液的制备
称取羌活粗粉100g,浸泡0.5h,加热煎煮提取3次,第1次加18倍重量的水,提取1.5h,第2次加13倍重量的水,提取1h,第3次加10倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至羌活重量的5倍g/ml待用。
2.9马齿苋提取液的制备
称取马齿苋100g,浸泡0.5h,加热煎煮提取3次,第1次加13倍重量的水,提取1.5h,第2次加10倍重量的水,提取1h,第3次加9倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至马齿苋重量的4倍g/ml待用。
2.10冻疮膏的制备
a)称取卡波姆941 0.5g,加入到50g的蒸馏水中,60℃水浴加热,边加热边搅拌,待混合均匀后,静置让其充分溶胀,待用;
b)称取甲基纤维素0.5g,加入到装有50g蒸馏水的烧杯中,静置让其充分溶胀,待用;
c)称取羧甲基纤维素钠0.2g,加入到装有40g蒸馏水的烧杯中,静置让其充分溶胀,待用;
d)称取冰晶形成剂AVC 0.5g,加入到装有50g蒸馏水的烧杯中,60℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
e)称取QM凝胶形成剂0.5g,加入到装有50g蒸馏水的烧杯中,60℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
f)分别称取柚子皮提取液2g,葱白提取液3g,细辛提取液3g,桂枝提取液3g,生姜提取液4g,红花提取液2g,桂圆提取液2g,羌活提取液3g,马齿苋提取液3g置于烧杯1中,并搅拌均匀;
g)取先前溶胀好的卡波姆941,甲基纤维素,羧甲基纤维素钠,冰晶形成剂AVC,QM凝胶形成剂加入到烧杯2中,用搅拌机搅拌均匀;
h)称取尼泊金甲酯0.05g、尼泊金乙酯0.05g,加入1,2-丙二醇3g加热使其溶解,待溶解后放入烧杯2中,再将烧杯2的物质放入烧杯1中,往烧杯1中加入香精0.25g,用搅拌机搅拌均匀即得一种可以消肿止痛止痒的冻疮膏。
实施例3
一种可以消肿止痛止痒的冻疮膏,含有以下重量份的原料:
一种可以消肿止痛止痒的冻疮膏的制备方法,包括以下步骤:
3.1柚子皮提取液的制备
称取柚子皮50g,剪碎后浸泡0.5h,加热煎煮提取3次,第1次加15倍重量的水,提取1h,第2次加12倍重量的水,提取1h,第3次加8倍重量的水,提取0.5h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至柚子皮重量的3倍g/ml待用。
3.2葱白提取液的制备
称取葱白50g,切碎后浸泡0.5h,加热煎煮提取3次,第1次加12倍重量的水,提取1h,第2次加10倍重量的水,提取1h,第3次加8倍重量的水,提取0.5h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至葱白重量的3倍g/ml待用。
3.3细辛提取液的制备
称取细辛粗粉500g,浸泡0.5h,加热煎煮提取3次,第1次加12倍重量的水,提取1h,第2次加10倍重量的水,提取1h,第3次加8倍重量的水,提取0.5h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至细辛重量的3倍g/ml待用。
3.4桂枝提取液的制备
称取桂枝粗粉50g,浸泡0.5h,加热煎煮提取3次,第1次加15倍重量的水,提取1h,第2次加10倍重量的水,提取1h,第3次加8倍重量的水,提取0.5h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至桂枝重量的1倍g/ml待用。
3.5生姜提取液的制备
称取生姜500g,切碎后浸泡0.5h,加热煎煮提取3次,第1次加13倍重量的水,提取1h,第2次加10倍重量的水,提取1h,第3次加8倍重量的水,提取0.5h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至生姜重量的3倍g/ml待用。
3.6红花提取液的制备
称取红花50g,浸泡0.5h,加热煎煮提取3次,第1次加18倍重量的水,提取1h,第2次加15倍重量的水,提取1h,第3次加8倍重量的水,提取0.5h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至红花重量的5倍g/ml待用。
3.7桂圆提取液的制备
称取桂圆50g,浸泡0.5h,加热煎煮提取3次,第1次加18倍重量的水,提取1h,第2次加15倍重量的水,提取1h,第3次加10倍重量的水,提取0.5h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至桂圆重量的3倍g/ml待用。
3.8羌活提取液的制备
称取羌活粗粉50g,浸泡0.5h,加热煎煮提取3次,第1次加15倍重量的水,提取1h,第2次加12倍重量的水,提取1h,第3次加8倍重量的水,提取0.5h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至羌活重量的4倍g/ml待用。
3.9马齿苋提取液的制备
称取马齿苋50g,浸泡0.5h,加热煎煮提取3次,第1次加12倍重量的水,提取1h,第2次加10倍重量的水,提取1h,第3次加8倍重量的水,提取1h,每次用3层纱布滤过,合并滤液,滤液的体积浓缩至马齿苋重量的3倍g/ml待用。
3.10冻疮膏的制备
a)称取卡波姆941 0.1g,加入到40g的蒸馏水中,60℃水浴加热,边加热边搅拌,待混合均匀后,静置让其充分溶胀,待用;
b)称取甲基纤维素0.1g,加入到装有40g蒸馏水的烧杯中,静置让其充分溶胀,待用;
c)称取羧甲基纤维素钠0.05g,加入到装有30g蒸馏水的烧杯中,静置让其充分溶胀,待用;
d)称取冰晶形成剂AVC0.1g,加入到装有40g蒸馏水的烧杯中,60℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
e)称取QM凝胶形成剂0.3g,加入到装有50g蒸馏水的烧杯中,60℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
f)分别称取柚子皮提取液0.5g,葱白提取液1g,细辛提取液1g,桂枝提取液0.5g,生姜提取液1g,红花提取液1g,桂圆提取液0.5g,羌活提取液1g,马齿苋提取液0.5g置于烧杯1中,并搅拌均匀;
g)取先前溶胀好的卡波姆941,甲基纤维素,羧甲基纤维素钠,冰晶形成剂AVC,QM凝胶形成剂加入到烧杯2中,用搅拌机搅拌均匀;
h)称取尼泊金甲酯0.01g、尼泊金乙酯0.01g,加入1,2-丙二醇2g加热使其溶解,待溶解后放入烧杯2中,再将烧杯2的物质放入烧杯1中,往烧杯1中加入香精0.1g,用搅拌机搅拌均匀即得一种可以消肿止痛止痒的冻疮膏。
实施例4
实施例1、2、3的理化指标如下:
4.1性状
本品为粘稠度适宜,细腻均匀,涂展性良好的冻疮膏。
4.2pH值检查
用润湿的PH试纸蘸取少量冻疮膏,pH为6-7。
4.3冷热试验
将冻疮膏封装于透明化妆品瓶中,于4℃的冰箱冷藏一周左右观察无分层现象。于55℃的恒温箱内24h,无分层变味等现象。
4.4离心试验
将冻疮膏封装于具塞试管中3000r/min离心20min,无分层现象。
4.5刺激性试验、过敏性实验
小白鼠背部剪去毛,分别涂抹按实施例1、2、3的冻疮膏于剪去毛的部位,和没涂部位进行比较,结果没有刺激性和过敏反应。
取实施例1克涂于志愿者(15-65岁,150人)手面上,过30分钟后观察,均没出现发红,发疹,起泡现象。
4.6室温放置实验
将实施例1、2、3所制的冻疮膏置于化妆品瓶中,室温静置考察6个月,无分层现象,用后感觉无变化,气味无变化。
实施例5
该冻疮膏综合效果考察
以下利用试用感觉来评价实施例1、2、3制造出的冻疮膏的功效。采用民意调查评分法,选取80名冻疮患者作为试用对象,任意等分成两组,分别用实施例1、2、3制备的冻疮膏治疗冻疮,每天使用,使用2周。各项使用效果总分为5分:5分为最高分,表示很好,非常满意;4分为较好;3分为可以接受;3分以下为不好,不能接受。以下为各项平均得分。结果见表1:
表1综合效果考察
综上所述,本发明所制的该冻疮膏吸收快,有很好的顺应性,具有保湿,止痛,止痒,淡化色斑,滋养等功效,能使患者的冻疮得到明显的改善,免疫力得到有效的提高,对于冻疮的防治疗效确切。
Claims (2)
1.一种可以消肿止痛止痒的冻疮膏,其特征在于,所述冻疮膏含有以下重量份的原料:
所述的柚子皮提取液通过以下方法制备:
称取柚子皮适量,剪碎后浸泡0.15-0.8h,加热煎煮提取3次,第1次加15-20倍重量的水,提取1-2.5h,第2次加12-18倍重量的水,提取1-2h,第3次加8-12倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至柚子皮重量的3-5倍g/ml,过滤即得;
所述的细辛提取液通过以下方法制备:
称取细辛粗粉适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加12-20倍重量的水,提取1-2.5h,第2次加10-16倍重量的水,提取1-2.5h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至细辛重量的3-6倍g/ml,过滤即得;
所述的葱白提取液通过以下方法制备:
称取葱白适量,切碎,浸泡0.15-0.8h,加热煎煮提取3次,第1次加12-16倍重量的水,提取1-2.5h,第2次加10-15倍重量的水,提取0.5-1.5h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至葱白重量的2-7倍g/ml,过滤即得;
所述的桂枝提取液通过以下方法制备:
称取桂枝粗粉适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加15-20倍重量的水,提取1-2.5h,第2次加10-15倍重量的水,提取0.5-1.5h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至桂枝重量的1-4倍g/ml,过滤即得;
所述的生姜提取液通过以下方法制备:
称取生姜适量,切碎,浸泡0.15-0.8h,加热煎煮提取3次,第1次加13-20倍重量的水,提取1-2.5h,第2次加10-15倍重量的水,提取1-2h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至生姜重量的3-7倍g/ml,过滤即得;
所述的红花提取液通过以下方法制备:
称取红花适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加18-25倍重量的水,提取1-3h,第2次加15-18倍重量的水,提取1-1.5h,第3次加8-12倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至红花重量的5-8倍g/ml,过滤即得;
所述的桂圆提取液通过以下方法制备:
称取桂圆适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加18-25倍重量的水,提取1-3h,第2次加15-20倍重量的水,提取1-2h,第3次加10-15倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至桂圆重量的3-6倍g/ml,过滤即得;
所述的羌活提取液通过以下方法制备:
称取羌活粗粉适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加15-20倍重量的水,提取1-2.5h,第2次加12-15倍重量的水,提取1-2h,第3次加8-12倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至羌活重量的4-7倍g/ml,过滤即得;
所述的马齿苋提取液通过以下方法制备:
称取马齿苋适量,浸泡0.15-0.8h,加热煎煮提取3次,第1次加12-15倍重量的水,提取0.5-2h,第2次加10-12倍重量的水,提取0.5-1.5h,第3次加8-10倍重量的水,提取0.5-1.5h,每次滤过,合并滤液,滤液的体积浓缩至马齿苋重量的3-6倍g/ml,过滤即得;
所述的香精为青瓜香精、茉莉香精、桂花香精、玫瑰香精、水蜜桃香精、菠萝香精或柠檬香精中任一种。
2.一种权利要求1所述的可以消肿止痛止痒的冻疮膏的制备方法,其特征在于,所述制备方法包括以下步骤:
a)称取卡波姆941 0.1-1份,加入到40-80份的蒸馏水中,40-70℃水浴加热,边加热边搅拌,待混合均匀后,静置让其充分溶胀,待用;
b)称取甲基纤维素0.1-1份,加入到装有40-80份蒸馏水的烧杯中,静置让其充分溶胀,待用;
c)称取羧甲基纤维素钠0.05-0.5份,加入到装有30-60份蒸馏水的烧杯中,静置让其充分溶胀,待用;
d)称取冰晶形成剂AVC0.1-1份,加入到装有40-80份蒸馏水的烧杯中,40-70℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
e)称取QM凝胶形成剂0.3-1份,加入到装有50-80份蒸馏水的烧杯中,40-70℃水浴加热,边加热边搅拌,静置让其充分溶胀,待用;
f)分别称取柚子皮提取液0.5-5份,葱白提取液1-6份,细辛提取液1-6份,桂枝提取液0.5-5份,生姜提取液1-6份,红花提取液1-5份,桂圆提取液0.5-4份,羌活提取液1-6份和马齿苋提取液0.5-6份搅拌均匀,得混合溶液;
g)取先前溶胀好的卡波姆941,甲基纤维素,羧甲基纤维素钠,冰晶形成剂AVC和QM凝胶形成剂搅拌均匀,得混合凝胶;
h)称取尼泊金甲酯0.01-0.08份、尼泊金乙酯0.01-0.08份,加入1,2-丙二醇2-6份加热使其溶解,然后加入到混合凝胶中,再将得到的混合物与步骤f)得到的混合溶液混匀,加入香精0.05-0.2份,搅拌均匀,即得可以消肿止痛止痒的冻疮膏。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610917697.8A CN106334176B (zh) | 2016-10-21 | 2016-10-21 | 一种可以消肿止痛止痒的冻疮膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610917697.8A CN106334176B (zh) | 2016-10-21 | 2016-10-21 | 一种可以消肿止痛止痒的冻疮膏及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106334176A CN106334176A (zh) | 2017-01-18 |
CN106334176B true CN106334176B (zh) | 2020-05-08 |
Family
ID=57840535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610917697.8A Active CN106334176B (zh) | 2016-10-21 | 2016-10-21 | 一种可以消肿止痛止痒的冻疮膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106334176B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108079131A (zh) * | 2018-01-18 | 2018-05-29 | 南宁圣特生物科技有限公司 | 含山茶籽精油深层修护消炎止痒冻疮膏及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079747A (zh) * | 2015-08-18 | 2015-11-25 | 郁秀芹 | 手用冻疮膏及其制备方法 |
CN105169326A (zh) * | 2015-09-28 | 2015-12-23 | 昆明理工大学 | 一种冻疮膏 |
-
2016
- 2016-10-21 CN CN201610917697.8A patent/CN106334176B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079747A (zh) * | 2015-08-18 | 2015-11-25 | 郁秀芹 | 手用冻疮膏及其制备方法 |
CN105169326A (zh) * | 2015-09-28 | 2015-12-23 | 昆明理工大学 | 一种冻疮膏 |
Also Published As
Publication number | Publication date |
---|---|
CN106334176A (zh) | 2017-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN103041173B (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
CN101791378B (zh) | 一种用于伤口止血、抗炎、生肌的中药制剂 | |
CN104147533A (zh) | 一种活血化瘀止痛乳膏及其制备方法 | |
CN104689066A (zh) | 一种用于治疗烧伤的中药组合物及其制备方法 | |
CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
CN104857290A (zh) | 一种治疗烧烫伤的中药消毒膏及其制备方法 | |
CN101229322A (zh) | 治疗外科和皮肤科疾病的外用药及其制备方法 | |
CN104873446B (zh) | 一种含肉桂油的牙膏 | |
CN103239662A (zh) | 兽用驱虫中药制剂 | |
KR100564659B1 (ko) | 생약 추출물을 함유하는 찜질용 패치제 조성물 및 이를 이용한 건강 찜질 파스 | |
CN106334176B (zh) | 一种可以消肿止痛止痒的冻疮膏及其制备方法 | |
CN101249186A (zh) | 一种兼治外伤、风湿痛、牙痛的中药油剂及其生产方法 | |
CN100387291C (zh) | 一种治疗肺结核的药物 | |
CN106822321B (zh) | 伤科黄水在制备治疗毛周角化症的药物中的应用 | |
CN103751708A (zh) | 一种治疗下肢静脉曲张的中药外用制剂及其制备方法 | |
CN102872187A (zh) | 一种外用毒疮膏及其制备方法 | |
CN105902690A (zh) | 一种应用于风湿性关节炎的中药香皂 | |
CN112401403A (zh) | 一种太赫兹光波结合中药制成的鞋垫及其制备方法 | |
CN105250685A (zh) | 一种用于治疗烧伤的中药组合物及其制备方法 | |
CN105106085A (zh) | 凹凸棒中草药防晒霜 | |
CN109394869A (zh) | 蒲蓉爽乳霜及其制备方法 | |
CN108355082A (zh) | 一种去脚气的中药足浴粉及其制备方法 | |
Khatoon et al. | Sibr (Aloe Barbadensis Miller.), A Potent Herb of Unani Medicine: A Review | |
CN107929492A (zh) | 一种治疗脓肿的壮医外用制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |